These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


711 related items for PubMed ID: 18162244

  • 1. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J.
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [Abstract] [Full Text] [Related]

  • 2. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 3. Correlating immunity with protection for HPV infection.
    Frazer I.
    Int J Infect Dis; 2007 Nov 01; 11 Suppl 2():S10-6. PubMed ID: 18162240
    [Abstract] [Full Text] [Related]

  • 4. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 01; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 5. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R, Gissmann L, Grundhewer H, Ikenberg H, Kaufmann AM, Klusmann J, Kopp I, Pfister H, Rzany B, Schneede P, Schneider A, Smola S, Winter-Koch N, Wutzler P, Gross G.
    Vaccine; 2009 Jul 23; 27(34):4551-9. PubMed ID: 19524337
    [Abstract] [Full Text] [Related]

  • 6. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
    Villa LL.
    Int J Infect Dis; 2007 Nov 23; 11 Suppl 2():S17-25. PubMed ID: 18162241
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases.
    Villa LL.
    Vaccine; 2006 Mar 30; 24 Suppl 1():S23-8. PubMed ID: 16194583
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA.
    J Am Osteopath Assoc; 2006 Mar 30; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [Abstract] [Full Text] [Related]

  • 9. Cervical cancer prevention in the human papilloma virus vaccine era.
    Ghazal-Aswad S.
    Ann N Y Acad Sci; 2008 Sep 30; 1138():253-6. PubMed ID: 18837904
    [Abstract] [Full Text] [Related]

  • 10. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M.
    Minerva Med; 2007 Apr 30; 98(2):121-30. PubMed ID: 17519854
    [Abstract] [Full Text] [Related]

  • 11. Decreasing risk: impact of HPV vaccination on outcomes.
    Hymel PA.
    Am J Manag Care; 2006 Dec 30; 12(17 Suppl):S473-83. PubMed ID: 17203991
    [Abstract] [Full Text] [Related]

  • 12. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar 30; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM, Bazaldua OV, Vargas L, Reile E.
    Postgrad Med; 2008 Jul 30; 120(2):79-84. PubMed ID: 18654072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human papilloma viruses and cancer in the post-vaccine era.
    Galani E, Christodoulou C.
    Clin Microbiol Infect; 2009 Nov 30; 15(11):977-81. PubMed ID: 19874381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.